Konomi Ikebe
Corporate Officer/Principal bei JAPAN PRIME REALTY INVESTMENT CORPORATION
Ursprung des Netzwerks ersten Grades von Konomi Ikebe
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Real Estate Investment Trusts | 3 | |
Chiba University
3
| College/University | Other Consumer Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Konomi Ikebe
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Tokyo Institute of Technology | College/University | Doctorate Degree | |
| PASONA GROUP INC. | Personnel Services | Director/Board Member | |
| AIDA ENGINEERING, LTD. | Industrial Machinery | Director/Board Member | |
| Rikkyo University College of Law & Politics | College/University | Corporate Officer/Principal | |
| Gyosei Certified Public Tax & Accountants'Co. | Corporate Officer/Principal | ||
| Nihon Employment Creation Organization, Inc. | Comptroller/Controller/Auditor | ||
| FIDEA HOLDINGS CO. LTD. | Regional Banks | Director/Board Member | |
| JUKI CORPORATION | Industrial Machinery | Director/Board Member | |
| The American Association of Immunologists | Corporate Officer/Principal | ||
| Advicelink Co. Ltd. | Director/Board Member | ||
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Founder | |
| The Japanese Society for Immunology | Corporate Officer/Principal | ||
La Jolla Institute for Allergy & Immunology
 La Jolla Institute for Allergy & Immunology Miscellaneous Commercial ServicesCommercial Services La Jolla Institute for Allergy & Immunology is a non-profit organization located in La Jolla, CA. The private company focuses on immunology research and aims to unravel the complexities of the immune system to tackle an array of diseases such as asthma, cancer, COVID-19, type 1 diabetes, and Parkinson's. The company is home to three research centers that focus on autoimmune conditions, cancer, and infectious diseases. The company offers various services such as bioinformatics, clinical studies, cryo-em, flow cytometry, histopathology, immunometabolism, microscopy & histology, and next-generation sequencing. The company also provides licensing opportunities and initiatives. The company was founded by Steve Pontell and is currently led by Erica Saphire as the CEO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RIKEN CORPORATION | Auto Parts: OEM | Corporate Officer/Principal | |
Tokyo Realty Investment Management, Inc.
 Tokyo Realty Investment Management, Inc. Investment ManagersFinance Tokyo Realty Investment Management, Inc. provides asset management services for investment corporations. The company was founded on April 28, 2000 and is headquartered in Tokyo, Japan. | Investment Managers | President |
Statistik
International
| Japan | 16 |
| Vereinigte Staaten | 3 |
Sektoral
| Producer Manufacturing | 4 |
| Consumer Services | 3 |
| Commercial Services | 3 |
| Finance | 3 |
| Health Technology | 3 |
Operativ
| Corporate Officer/Principal | 12 |
| Director/Board Member | 9 |
| Independent Dir/Board Member | 3 |
| President | 2 |
| Comptroller/Controller/Auditor | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Yasuyuki Ishii | 8 |
| Yutaka Hori | 5 |
| Kiyoe Kado | 4 |
| Masato Denawa | 2 |
| Nobuhisa Kusanagi | 2 |
| Yoshihiro Jozaki | 2 |
- Börse
- Insiders
- Konomi Ikebe
- Unternehmensverbindungen
